Address:

Metropolitan House , 2 Salisbury Road , Mosely , Birmingham B13 8JS

Telephone:

0121 442 4600

Fax:

0121 442 4611

Email:

info@henderson-morley.com

Website:

www.henderson-morley.com

Biotechnology company

Executive Chairman:

Andrew Knight (12.2% holding)

Chief Executive:

Ian Pardoe (8.7% holding)

Finance Director:

Christopher Pate (0% holding)

Director:

James Hill (1.1% holding)

Barclays: 11.2%

Michael P Dunne: 6.1%

Billam AG: 4.8%

Nominated Adviser:

Brewin Dolphin Securities

Nominated Broker:

Rivington Street

Solicitors:

n/a

Auditors:

Moore Stephens

Registrar:

Neville Registrars

Entry on AIM:

11/9/2001

Issue Price:

4.0p

Interim Results:

Jan

Final Results:

Sep

Year End:

Apr

Accounts Due:

Sep

Int div payment:

n/a

Fin div payment:

n/a

Int net div per share:

nil

Fin net div per share:

nil

	2009	2008
Turnover:	£0.08m	£0.02m
Pre-tax profit:	£ (1.10m)	£ (1.30m)
EPS:	(0.17) p	(0.24) p

Henderson Morley raises £0.3m 29/10/2009

Henderson Morley seeks £1m 04/06/2009

Carp deal cheers Henderson 22/05/2008

Herpes group for sale 29/01/2008

Herpes group fishes for funds 02/02/2007